Senior Research Scientist

Senior Research Scientist
CMC Product & Process Development
CMC Injectable Drug Product Development
Måløv, Denmark.

Help shape the future of injectable drug products

As our new Senior Research Scientist, you will help influence Novo Nordisk’s promising pipeline and contribute to the development of tomorrow’s drug products. This role involves driving both early- and late‑stage development projects, supported by strong scientific expertise within formulation development of peptides, proteins, antibodies, or minibinders.

If you are looking to join a company where your professional growth matters just as much as the work you deliver, this is your opportunity to join us in Chemistry, Manufacturing and Control (CMC) Injectable Drug Product Development. Apply today and lead with scientific impact.

This is a temporary position for 18 months in office 5 days a week in Målev.

Your new role 

As our new experienced research scientist, you will play a key role in driving formulation and process development to secure optimal pharmaceutical characteristics and product stability. You will take scientific ownership of projects within one of our drug modalities and help strengthen knowledge sharing across the portfolio, ensuring early identification of formulation challenges. 

Your impact and responsibilities: 

• Set the scientific direction for designing, interpreting and reporting formulation studies. 

• Strengthen knowledge sharing by working closely with scientists, lab technicians and specialists to plan and execute studies on drug products. 

• Own end‑to‑end process by defining documentation strategies for internal and external purposes, including clinical trial applications and patent submissions. 

• Collaborate widely with internal stakeholders, including Global Research, Regulatory Affairs, Quality Assurance and Analytical Development. 

In this role, you are expected to set a clear scientific direction, spot opportunities and inspire your colleagues. 

Your skills and qualifications

To succeed in this role, you hold a PhD or Master’s degree within Pharmaceutical Sciences, Engineering or another relevant natural science field. You also bring:

• At least +3 years of experience within R&D and drug product development across phase I–III. 
• Hands‑on experience with injectable protein/peptide/antibody/minibinder formulation and stability studies.
• Familiarity with phase‑appropriate quality expectations and documentation.
• An innovative, proactive and engaging mindset that moves projects forward.
• Proven ability to work collaboratively in a multi‑stakeholder setting.
• Communicate fluently in written and spoken English.

On a personal level, you are a team player who also enjoys driving your own area of responsibility independently. You are not afraid to lead the way for your colleagues and stakeholders. You are eager to see things moving forward in a dynamic environment where projects and processes vary and therefore require you to be flexible and willing to adapt. Additionally, you can communicate complex content to people with different backgrounds and skills, motivating them to hear and follow your ideas and suggestions.

Your new area

CMC Injectable Drug Product Development is part of CMC Product & Process Development. We develop formulations and production processes for injectable biopharmaceutical products. We are approximately 100 employees organised into six teams, all located in Måløv. We manage projects from early development (Phase 1–2) through late‑stage and process validation (Phase 3–PV), covering GLP‑1 products, insulins, monoclonal antibodies and minibinders. 

We foster a collaborative culture where we care for one another and encourage initiative. You will join a team where you are empowered to drive projects forward and grow professionally. 

Working at Novo Nordisk

Every day we seek the solutions that defeat serious chronic diseases. To do this, we approach our work with an unconventional spirit, a rare determination and a constant curiosity. For over 100 years this unordinary mindset has seen us build a company unlike any other. One where a collective passion for our purpose, mutual respect and a willingness to go beyond what we know delivers extraordinary results.

More information

For further information, please contact: 

• Jonas Oldenburg Jørgensen, +45 30 75 65 04 

• Tenna Natascha Mose-Jensen, +45 30 79 62 24

 Deadline

1 March 2026.

Please note, applications will be reviewed, and interviews will be conducted on an on-going basis.

While not mandatory, we strongly encourage the submission of a cover letter, explaining why you are the ideal candidate to join us in CMC Injectable Drug Product Development. Please refrain from adding a photo to your CV to ensure fair and efficient processing.

We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.

At Novo Nordisk, we're not chasing quick fixes – we're creating lasting change for long-term health. For over 100 years, we've been driven by a single purpose: to defeat serious chronic diseases and help millions of people live healthier lives. This dedication fuels our constant curiosity and inspires us to push the boundaries of what's possible in healthcare. We embrace diverse perspectives, seek out bold ideas, and build partnerships rooted in shared purpose. Together, we're making healthcare more accessible, treating and preventing diseases, and pioneering solutions that create change spanning generations. When you join us, you become part of something bigger – a legacy of impact that reaches far beyond today.